Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: Perioperative and Survival Outcomes

BACKGROUND: Immune checkpoint inhibitors (ICI) improve survival in patients with late-stage esophageal squamous cell carcinoma (ESCC) but have not been fully evaluated in locally advanced ESCC. METHOD: We retrospectively assessed outcomes of consecutive, treatment-naïve locally advanced ESCC (stage...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Xiao, Zhao, Weixin, Li, Bin, Yu, Yongfu, Ma, Yuan, Thomas, Mathew, Zhang, Yawei, Xiang, Jiaqing, Zhang, Yiliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226664/
https://www.ncbi.nlm.nih.gov/pubmed/35756623
http://dx.doi.org/10.3389/fonc.2022.810898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226664/
https://www.ncbi.nlm.nih.gov/pubmed/35756623
http://dx.doi.org/10.3389/fonc.2022.810898

Ejemplares similares